CNBC July 08, 2026 • 13:16

Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs – many are finding ways around it - CNBC

By Annika Kim Constantino

Around 36% of employers said they provide coverage of GLP-1s for both diabetes and weight loss, the same as 2025 and up from 34% in 2024, the survey said.

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions.
As new GLP-… [+3862 chars]

Read Full Article on Original Site ↗ ← Back to News List

Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs – many are finding ways around it - CNBC

More from CNBC

2 snow leopards at a California sanctuary get Valley fever as fungus from soil also threatens humans - Yahoo

Whole-body MRI screenings gain popularity despite concerns from medical experts - ABC7 Los Angeles

Is COVID returning? Summer uptick of virus may have begun in California - Honolulu Star-Advertiser

Opinion | Cuts to anti-AIDS foreign aid take a toll in Africa - The Washington Post